Benitec and GenScript, CytRx, AVI BioPharma, Frost & Sullivan, Siemens and Biomax Informatics, Hybridon, and Innovation Philadelphia and Acuity Pharmaceuticals | GenomeWeb

Benitec Settles Lawsuit Against GenScript, Signs on Strategic Advisors

Benitec said last month that it has settled its patent infringement lawsuit against GenScript. Under the terms of the settlement, GenScript has taken a global, non-exclusive license to Benitec’s ddRNAi technology.

According to Benitec, the arrangement completely settles all claims the company had asserted against GenScript. Specific terms of the deal were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.